Literature DB >> 15308923

Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects.

Ann P Streissguth1, Fred L Bookstein, Helen M Barr, Paul D Sampson, Kieran O'Malley, Julia Kogan Young.   

Abstract

Clinical descriptions of patients with Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effects (FAE) suggest major problems with adaptive behavior. Five operationally defined adverse outcomes and 18 associated risk/protective factors were examined using a Life History Interview with knowledgeable informants of 415 patients with FAS or FAE (median age 14 years, range 6-51; median IQ 86, range 29-126). Eighty percent of these patients were not raised by their biological mothers. For adolescents and adults, the life span prevalence was 61% for Disrupted School Experiences, 60% for Trouble with the Law, 50% for Confinement (in detention, jail, prison, or a psychiatric or alcohol/drug inpatient setting), 49% for Inappropriate Sexual Behaviors on repeated occasions, and 35% for Alcohol/Drug Problems. The odds of escaping these adverse life outcomes are increased 2- to 4-fold by receiving the diagnosis of FAS or FAE at an earlier age and by being reared in good stable environments. Copyright 2004 Lippincott Williams and Wilkins, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15308923     DOI: 10.1097/00004703-200408000-00002

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  252 in total

1.  Ventromedian forebrain dysgenesis follows early prenatal ethanol exposure in mice.

Authors:  Elizabeth A Godin; Deborah B Dehart; Scott E Parnell; Shonagh K O'Leary-Moore; Kathleen K Sulik
Journal:  Neurotoxicol Teratol       Date:  2010-11-11       Impact factor: 3.763

2.  Misattributions and Potential Consequences: The Case of Child Mental Health Problems and Fetal Alcohol Spectrum Disorders.

Authors:  John D Mclennan
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

Review 3.  Fetal Alcohol Spectrum Disorders: A Review of the Neurobehavioral Deficits Associated With Prenatal Alcohol Exposure.

Authors:  Sarah N Mattson; Gemma A Bernes; Lauren R Doyle
Journal:  Alcohol Clin Exp Res       Date:  2019-05-02       Impact factor: 3.455

4.  Improving Recognition of Children Affected by Prenatal Alcohol Exposure: Detection of Exposure in Pediatric Care.

Authors:  Ami C Bax; Carrie D Geurts; Tatiana N Balachova
Journal:  Curr Dev Disord Rep       Date:  2015-09-01

5.  Assessment of benefits of a universal screen for maternal alcohol use during pregnancy.

Authors:  Anne E Gifford; Kathleen J Farkas; Leila W Jackson; Christopher D Molteno; Joseph L Jacobson; Sandra W Jacobson; Cynthia F Bearer
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

6.  Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder.

Authors:  Jessie Newville; Carlos Fernando Valenzuela; Lu Li; Lauren L Jantzie; Lee Anna Cunningham
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

7.  Effect of predictive cuing on response inhibition in children with heavy prenatal alcohol exposure.

Authors:  Jessica W O'Brien; Andria L Norman; Susanna L Fryer; Susan F Tapert; Martin P Paulus; Kenneth Lyons Jones; Edward P Riley; Sarah N Mattson
Journal:  Alcohol Clin Exp Res       Date:  2012-10-24       Impact factor: 3.455

8.  Strain-specific programming of prenatal ethanol exposure across generations.

Authors:  Daniel O Popoola; Michael E Nizhnikov; Nicole M Cameron
Journal:  Alcohol       Date:  2017-01-04       Impact factor: 2.405

9.  Gestational risks and psychiatric disorders among indigenous adolescents.

Authors:  Les B Whitbeck; Devan M Crawford
Journal:  Community Ment Health J       Date:  2008-11-08

10.  Cingulate gyrus morphology in children and adolescents with fetal alcohol spectrum disorders.

Authors:  Olivia A Bjorkquist; Susanna L Fryer; Allan L Reiss; Sarah N Mattson; Edward P Riley
Journal:  Psychiatry Res       Date:  2010-01-18       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.